Searching News Database: Dr. Reddy's Laboratories
HSMN NewsFeed - 3 Dec 2018
Neurelis Announces Acquisition Of Aegis Therapeutics, A Leading Drug Delivery Technology Company
Neurelis Announces Acquisition Of Aegis Therapeutics, A Leading Drug Delivery Technology Company
HSMN NewsFeed - 3 Oct 2011
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva
HSMN NewsFeed - 1 Apr 2011
Promius Pharma and Valeant Form Collaboration to Market Cloderm(R) Cream in the United States
Promius Pharma and Valeant Form Collaboration to Market Cloderm(R) Cream in the United States
HSMN NewsFeed - 7 Dec 2009
Xencor Appoints Former ZymoGenetics CEO, Bruce Carter, to Chairman of the Board
Xencor Appoints Former ZymoGenetics CEO, Bruce Carter, to Chairman of the Board
HSMN NewsFeed - 5 Feb 2009
Dr. Reddy's Announces Five ANDA Approvals and Generic Product Launches in the US Market
Dr. Reddy's Announces Five ANDA Approvals and Generic Product Launches in the US Market
HSMN NewsFeed - 14 Oct 2008
Dr. Reddy's Wholly-Owned Subsidiary Promius Pharma Launches EPICERAM(R) Skin Barrier Emulsion
Dr. Reddy's Wholly-Owned Subsidiary Promius Pharma Launches EPICERAM(R) Skin Barrier Emulsion
HSMN NewsFeed - 18 Sep 2008
Dr. Reddy's Formally Announces its US Specialty Business, Promius Pharma, LLC.
Dr. Reddy's Formally Announces its US Specialty Business, Promius Pharma, LLC.
HSMN NewsFeed - 21 Jan 2008
Dr. Reddy's Announces Settlement of Exelon(R) (rivastigmine tartrate) ANDA Litigation With Novartis
Dr. Reddy's Announces Settlement of Exelon(R) (rivastigmine tartrate) ANDA Litigation With Novartis
HSMN NewsFeed - 19 Nov 2007
Ceragenix and Dr. Reddy's Enter Into Distribution and Supply Agreement for EpiCeram(R)
Ceragenix and Dr. Reddy's Enter Into Distribution and Supply Agreement for EpiCeram(R)
HSMN NewsFeed - 30 Apr 2007
Dr Reddy's launches Reditux(TM) - Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma
Dr Reddy's launches Reditux(TM) - Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma
HSMN NewsFeed - 27 Dec 2006
Dr. Reddy's Announces Final Approval of Ondansetron Tablets with 180-Days of Marketing Exclusivity
Dr. Reddy's Announces Final Approval of Ondansetron Tablets with 180-Days of Marketing Exclusivity
HSMN NewsFeed - 10 Oct 2006
Dr. Reddy's Announces Settlement of Imitrex(R) Litigation with GlaxoSmithKline
Dr. Reddy's Announces Settlement of Imitrex(R) Litigation with GlaxoSmithKline
HSMN NewsFeed - 23 Jun 2006
Dr. Reddy's launches authorized generic versions of Proscar(R) and Zocor(R)
Dr. Reddy's launches authorized generic versions of Proscar(R) and Zocor(R)
Additional items found! 36
Members Archive contains
36 additional stories matching:
Dr. Reddy's Laboratories
(Password required)
Dr. Reddy's Laboratories
(Password required)